Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of aCandida albicansVaccine
Open Access
- 1 October 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (10) , 5462-5470
- https://doi.org/10.1128/iai.70.10.5462-5470.2002
Abstract
Mice immunized with heat-inactivated, whole yeast-form cells (Y cells) of Candida albicans developed intense, specific humoral and cell-mediated immune responses. However, they were modestly protected against a lethal challenge by the fungus, and their sera did not confer passive protection upon nonimmunized animals. Surprisingly, this immune serum conferred an elevated degree of passive protection to normal and SCID mice when preadsorbed on whole C. albicans cells. After adsorption, no antibodies specific to mannoprotein (MP)-rich extracts or secretions were detected by indirect enzyme-linked immunosorbent assay and no serum reaction with the fungal cell surface was seen in immunofluorescence assays. However, this serum had totally preserved the level of other antibodies, in particular those reacting with β-1,3 and β-1,6 glucan (GG). The hypothesis that anti-GG antibodies contributed to the passive protection was suggested by the following circumstantial evidence: (i) mice immunized with C. albicans cells treated with dithiothreitol and protease (YDP cells), which exposed GG on their surfaces and generated anti-GG but not anti-MP antibodies, were substantially protected against a lethal fungus challenge; (ii) the sera, and their immunoglobulin fractions, of mice immunized with YDP cells transferred protection to nonimmune animals; and (iii) this passive protection was substantially abolished by preadsorption on GG but not on intact cells. Overall, our findings demonstrate that some anti-Candida antibodies can block the protective potential of immune serum, a potential to which anti-GG antibodies appear to contribute. Our observations may also help explain why subjects with elevated anti-Candida antibody titers, inclusive of anti-MP and anti-GG antibodies, remain nonetheless susceptible to invasive candidiasis.Keywords
This publication has 94 references indexed in Scilit:
- Protective immunity in experimental Candida vaginitisResearch in Immunology, 1998
- Antifungal Resistance Trends Towards the Year 2000Drugs, 1997
- Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature?Immunology Today, 1997
- Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?Zentralblatt für Bakteriologie, 1996
- Preliminary Assessment of a Human Recombinant Antibody Fragment to hsp90 in Murine Invasive CandidiasisThe Journal of Infectious Diseases, 1995
- Immunoprotection against systemic candidiasis in miceInternational Immunology, 1995
- Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicansJournal of General Microbiology, 1990
- Cell Wall Components of Candida albicans as Immunomodulators: Induction of Natural Killer and Macrophage-mediated Peritoneal Cell Cytotoxicity in Mice by Mannoprotein and Glucan FractionsMicrobiology, 1988
- Changes in the Plasma Membrane of Regenerating Protoplasts of Candida albicans as Revealed by Freeze-fracture Electron MicroscopyMicrobiology, 1986
- Candida albicans infections in actively and passively immunized animalsMycopathologia, 1953